Trial Profile
A Phase II Study of Hemospan® Versus Voluven® to Evaluate Vascular Resistance and Forearm Blood Flow, and to Assess Local Skin Blood Flow and Tissue Oxygenation in the Ischemic Foot of Patients With Chronic Critical Limb Ischemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2014
Price :
$35
*
At a glance
- Drugs Human haemoglobin (Primary)
- Indications Chronic limb-threatening ischemia; Peripheral ischaemia
- Focus Therapeutic Use
- Sponsors Sangart
- 10 Oct 2014 New trial record